MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 1 filers reported holding MAST THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $7,000 | +40.0% | 54,724 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 54,724 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | 0.0% | 54,724 | +317.0% | 0.00% | – |
| Q2 2016 | $6,000 | +50.0% | 13,124 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -33.3% | 13,124 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | -14.3% | 13,124 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | +16.7% | 13,124 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | 0.0% | 13,124 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | -14.3% | 13,124 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | -12.5% | 13,124 | -10.3% | 0.00% | – |
| Q3 2014 | $8,000 | -11.1% | 14,624 | 0.0% | 0.00% | – |
| Q2 2014 | $9,000 | -10.0% | 14,624 | 0.0% | 0.00% | – |
| Q1 2014 | $10,000 | -33.3% | 14,624 | -50.0% | 0.00% | – |
| Q4 2013 | $15,000 | +150.0% | 29,248 | +100.0% | 0.00% | – |
| Q3 2013 | $6,000 | 0.0% | 14,624 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 14,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,294,934 | $599,000 | 0.42% |
| Ancora Advisors LLC | 1,234,599 | $571,000 | 0.09% |
| Alyeska Investment Group, L.P. | 1,900,000 | $1,757,000 | 0.07% |
| THOMPSON DAVIS & CO., INC. | 80,000 | $37,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,466,249 | $678,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 532,776 | $246,000 | 0.03% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 123,450 | $57,000 | 0.02% |
| WEXFORD CAPITAL LP | 89,360 | $41,000 | 0.00% |
| FRANKLIN RESOURCES INC | 12,046,100 | $5,570,000 | 0.00% |
| Renaissance Technologies | 1,535,000 | $710,000 | 0.00% |